GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY has a total of 26 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are PROMEDIOR INC, PAION DEUTSCHLAND GMBH and CHEMOKINE THERAPEUTICS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 26 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Analysing materials | |
#6 | Microorganisms | |
#7 | Measuring microorganism processes | |
#8 | Special acyclic compounds | |
#9 | Chemical or physical processes | |
#10 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Rosenberg Steven A | 4 |
#2 | Loktionova Natalia A | 2 |
#3 | Mitchell James B | 2 |
#4 | Pegg Anthony E | 2 |
#5 | Bates Susan E | 2 |
#6 | Jacobson Kenneth A | 2 |
#7 | Morgan Richard A | 2 |
#8 | Piekarz Richard L | 2 |
#9 | Moschel Robert C | 2 |
#10 | Oishi Shinya | 1 |
Publication | Filing date | Title |
---|---|---|
AU2008270735A1 | Dendrimer conjugates of agonists and antagonists of the GPCR superfamily | |
AU2008206442A1 | gp100-specific T cell receptors and related materials and methods of use | |
AU2006304659A1 | In situ assembly of protein microarrays | |
AU2005336093A1 | Adoptive immunotherapy with enhanced T lymphocyte survival | |
AU2004284075A1 | Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto | |
AU2003212459A1 | An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |